Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Otsuka acquires ADHD drug in $100M deal for Neurovance
Otsuka acquires ADHD drug in $100M deal for Neurovance
Otsuka acquires ADHD drug in $100M deal for Neurovance
Submitted by
admin
on March 6, 2017 - 11:48am
Source:
BioPharma Dive
News Tags:
Otsuka
ADHD
Neurovance
centanafadine
M&A
Headline:
Otsuka acquires ADHD drug in $100M deal for Neurovance
Do Not Allow Advertisers to Use My Personal information
